BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20666813)

  • 1. The invasive growth potential of residual melanoma and melanoma in situ.
    DeBloom JR; Zitelli JA; Brodland DG
    Dermatol Surg; 2010 Aug; 36(8):1251-7. PubMed ID: 20666813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
    Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
    Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    Bricca GM; Brodland DG; Ren D; Zitelli JA
    J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
    Iorizzo LJ; Chocron I; Lumbang W; Stasko T
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs surgery for the treatment of melanoma in situ: a review.
    Dawn ME; Dawn AG; Miller SJ
    Dermatol Surg; 2007 Apr; 33(4):395-402. PubMed ID: 17430372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins.
    Kimyai-Asadi A; Katz T; Goldberg LH; Ayala GB; Wang SQ; Vujevich JJ; Jih MH
    Dermatol Surg; 2007 Dec; 33(12):1434-9; discussion 1439-41. PubMed ID: 18076608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
    Bene NI; Healy C; Coldiron BM
    Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
    Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
    Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Marginally Recurrent Melanoma After Primary Excision: A Multisite Retrospective Analysis of 140 Cases Referred for Mohs Surgery.
    Soh JM; Brodland DG; Zitelli JA
    Dermatol Surg; 2024 Feb; 50(2):131-136. PubMed ID: 37962121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of local recurrence of melanoma at the primary excision site.
    Heenan PJ; Ghaznawie M
    Br J Plast Surg; 1999 Apr; 52(3):209-13. PubMed ID: 10474473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical margins for melanoma in situ.
    Kunishige JH; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2012 Mar; 66(3):438-44. PubMed ID: 22196979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps Clinic.
    Shumaker PR; Kelley B; Swann MH; Greenway HT
    Dermatol Surg; 2009 Aug; 35(8):1263-70. PubMed ID: 19438663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
    Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
    Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the depth of excision of melanoma: A survey of US physicians.
    DeFazio JL; Marghoob AA; Pan Y; Dusza SW; Khokhar A; Halpern A
    Arch Dermatol; 2010 Sep; 146(9):995-9. PubMed ID: 20644028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
    Leach BC; Kulbersh JS; Day TA; Cook J
    Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
    Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
    Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision of melanoma in situ on nonchronically sun-exposed skin using 5-mm surgical margins.
    Welch A; Reid T; Knox J; Wilson ML
    J Am Acad Dermatol; 2014 Oct; 71(4):834-5. PubMed ID: 25219710
    [No Abstract]   [Full Text] [Related]  

  • 20. Upstaging From Melanoma in Situ to Invasive Melanoma on the Head and Neck After Complete Surgical Resection.
    Gardner KH; Hill DE; Wright AC; Brewer JD; Arpey CJ; Otley CC; Roenigk RK; Baum CL
    Dermatol Surg; 2015 Oct; 41(10):1122-5. PubMed ID: 26356849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.